rediff News http://www.rediff.com/tags/biotechnology+regulatory+authority+of+india+b India's largest news and entertainment service online.. en-us Wed, 31 Aug 16 08:14:04 +0000 Wed, 31 Aug 16 08:14:04 +0000 http://www.rediff.com/push Rediff feeds Copyright: (C) 2009 Rediff.com India Limited. All Rights Reserved. <![CDATA[Educating India, in a B-Grade American style]]> http://www.rediff.com/money/column/guest-educating-india-in-a-b-grade-american-style/20100318.htm Wed, 31 Aug 2016 13:44:04 +0530 <![CDATA[Finance Minister P Chidambaram's speech]]> http://www.rediff.com/money/report/bud26/20070228.htm Wed, 31 Aug 2016 13:44:04 +0530 <![CDATA[Chidambaram's Budget speech]]> http://www.rediff.com/money/report/speech/20060228.htm Wed, 31 Aug 2016 13:44:04 +0530 <![CDATA[Biotech sector eyes $4,500 mn by '10]]> http://www.rediff.com/money/report/bio/20051201.htm Wed, 31 Aug 2016 13:44:04 +0530 <![CDATA[These startups have healing touch]]> http://economictimes.indiatimes.com/small-biz/startups/these-startups-have-healing-touch/articleshow/53695377.cms Wed, 31 Aug 2016 13:44:04 +0530 <![CDATA[Developments in Bio-Technology Sector]]> http://pib.nic.in/newsite/PrintRelease.aspx?relid=148242 Wed, 31 Aug 2016 13:44:04 +0530 <![CDATA[Takeda and Seattle Genetics Announce Positive Data from Phase 3 ALCANZA Clinical Trial of ADCETRIS® Brentuximab Vedotin for CD30 Expressing Cutaneous...]]> http://news.indiaonline.in/press-releases/Takeda-and-Seattle-Genetics-Announce-Positive-Data-from-Phase-ALCANZA-Clinical-Trial-of-ADCETRIS-Brentuximab-Vedotin-for-CD-Expressing-Cutaneous-T-Cell-Lymphoma-37485 Wed, 31 Aug 2016 13:44:04 +0530 <![CDATA[Opening For Group Leader]]> http://www.siasat.com/news/opening-group-leader-993473/ Wed, 31 Aug 2016 13:44:04 +0530